Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade - PubMed (original) (raw)
Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade
Norimoto Nakamura et al. Hum Pathol. 2005 Jul.
Erratum in
- Hum Pathol. 2006 Apr;37(4):503
Abstract
Gastrointestinal stromal tumors (GISTs) have a wide spectrum of biologic behavior ranging from benign to malignant. Risk grading based on tumor size and mitotic counts has been proposed in an effort to predict the adverse outcome of GIST in the literature so far. Recent molecular studies have reported the prognostic values of several parameters, including alteration of cell-cycle regulators. The aim of this study was to elucidate the prognostic values of risk grade and alterations of cell-cycle-related proteins, including Ki-67, cyclin A, cyclin B1, cyclin D1, cyclin E, p16, p21, p27, p53, cdc2, and cdk2, in addition to the conventional factors. Eighty cases of primary c-kit-positive GISTs were classified into 2 cases of very-low-risk grade, 20 cases of low-risk grade, 25 cases of intermediate-risk grade, and 33 cases of high-risk grade. The risk grade was correlated with the presence of metastases and/or recurrence. A high level of Ki-67 and cyclin A expression was correlated with risk grade (P = .0027 and .0441, respectively). Overexpression of G2-M regulators, such as cyclin A, cyclin B1, and cdc2, was associated with the Ki-67 labeling index (LI) (P = .0007, .0475, and .0040, respectively). According to univariate analysis, tumor grade (high risk), tumor size (> or =5 cm), mitotic counts (> or =5/50 high-power fields), Ki-67 LI (> or =4.92%), cyclin A LI (> or =1.61%), and cdc2 LI (> or =1.25%) were all found to be significantly associated with a shorter period of disease-free survival (P = .0001, .0270, .0004, .0001, .0001, and .0011, respectively). According to multivariate analysis, both high Ki-67 LI and high-risk grade were found to be significantly associated with a shorter period of disease-free survival (P = .0083 and .0246, respectively). In conclusion, our results strongly support the hypothesis that Ki-67 LI and risk grade are useful for predicting the aggressive biologic behavior of GISTs. Furthermore, alteration of G2-M regulators, such as cyclin A, cyclin B1, and cdc2, is also a useful marker for predicting aggressive behavior and play an important role, at least in part, in the cell proliferation of GIST.
Similar articles
- Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1.
Nemoto Y, Mikami T, Hana K, Kikuchi S, Kobayashi N, Watanabe M, Okayasu I. Nemoto Y, et al. Pathol Int. 2006 Dec;56(12):724-31. doi: 10.1111/j.1440-1827.2006.02038.x. Pathol Int. 2006. PMID: 17096729 - Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH, Tai MH, Chuah SK, Chen HH, Lin JW, Huang HY, Chou YP, Yi LN, Kuo CM, Changchien CS. Hu TH, et al. J Surg Oncol. 2008 Aug 1;98(2):117-23. doi: 10.1002/jso.21094. J Surg Oncol. 2008. PMID: 18521824 - Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY, Huang WW, Lin CN, Eng HL, Li SH, Li CF, Lu D, Yu SC, Hsiung CY. Huang HY, et al. Ann Surg Oncol. 2006 Dec;13(12):1633-44. doi: 10.1245/s10434-006-9188-4. Epub 2006 Sep 30. Ann Surg Oncol. 2006. PMID: 17013685 - Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB. Møller MB. Dan Med Bull. 2003 May;50(2):118-38. Dan Med Bull. 2003. PMID: 12812137 Review. - The Ki-67 protein: from the known and the unknown.
Scholzen T, Gerdes J. Scholzen T, et al. J Cell Physiol. 2000 Mar;182(3):311-22. doi: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. J Cell Physiol. 2000. PMID: 10653597 Review.
Cited by
- Prediction of Ki-67 expression in gastrointestinal stromal tumors using radiomics of plain and multiphase contrast-enhanced CT.
Liu Y, He C, Fang W, Peng L, Shi F, Xia Y, Zhou Q, Zhang R, Li C. Liu Y, et al. Eur Radiol. 2023 Nov;33(11):7609-7617. doi: 10.1007/s00330-023-09727-5. Epub 2023 Jun 2. Eur Radiol. 2023. PMID: 37266658 - The relationship between Ki-67 expression and imaging signs and pathological features in GISTs.
Xiao L, Zhang Y, Wang Y, Liu L, Pan Y. Xiao L, et al. Front Surg. 2023 Mar 8;10:1095924. doi: 10.3389/fsurg.2023.1095924. eCollection 2023. Front Surg. 2023. PMID: 36969752 Free PMC article. - Ki67 for evaluating the prognosis of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Li J, Wang AR, Chen XD, Pan H, Li SQ. Li J, et al. Oncol Lett. 2022 Jun;23(6):189. doi: 10.3892/ol.2022.13309. Epub 2022 Apr 27. Oncol Lett. 2022. PMID: 35527778 Free PMC article. - Imaging findings of gastrointestinal tract tumors in children and adolescents.
Özcan HN, Yavuz ÖÖ, Ekinci S, Oguz B, Kutluk T, Haliloglu M. Özcan HN, et al. Insights Imaging. 2022 Mar 22;13(1):51. doi: 10.1186/s13244-022-01193-9. Insights Imaging. 2022. PMID: 35316432 Free PMC article. Review. - Risk stratification of gastrointestinal stromal tumors by Nanostring gene expression profiling.
Nowak K, Formenti K, Huang J, Bigras G, Chu Q, Adam BA, Izevbaye I. Nowak K, et al. J Cancer Res Clin Oncol. 2022 Jun;148(6):1325-1336. doi: 10.1007/s00432-022-03924-3. Epub 2022 Jan 28. J Cancer Res Clin Oncol. 2022. PMID: 35089395
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous